BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gijbels D, Dalgas U, Romberg A, de Groot V, Bethoux F, Vaney C, Gebara B, Medina CS, Maamâgi H, Rasova K, de Noordhout BM, Knuts K, Feys P. Which walking capacity tests to use in multiple sclerosis? A multicentre study providing the basis for a core set. Mult Scler 2012;18:364-71. [PMID: 21952098 DOI: 10.1177/1352458511420598] [Cited by in Crossref: 92] [Cited by in F6Publishing: 87] [Article Influence: 8.4] [Reference Citation Analysis]
Number Citing Articles
1 Edwards EM, Kegelmeyer DA, Kloos AD, Nitta M, Raza D, Nichols-Larsen DS, Fritz NE. Backward Walking and Dual-Task Assessment Improve Identification of Gait Impairments and Fall Risk in Individuals with MS. Mult Scler Int 2020;2020:6707414. [PMID: 32963832 DOI: 10.1155/2020/6707414] [Reference Citation Analysis]
2 Bradford EH, Baert I, Finlayson M, Feys P, Wagner J. Feasibility of an International Multiple Sclerosis Rehabilitation Data Repository: Perceived Challenges and Motivators for Sharing Data. Int J MS Care 2018;20:17-26. [PMID: 29507539 DOI: 10.7224/1537-2073.2016-009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
3 Motl RW, Pilutti LA, Sandroff BM, Klaren R, Balantrapu S, Mcauley E, Sosnoff JJ, Fernhall B. Rationale and design of a randomized controlled, clinical trial investigating a comprehensive exercise stimulus for improving mobility disability outcomes in persons with multiple sclerosis. Contemporary Clinical Trials 2013;35:151-8. [DOI: 10.1016/j.cct.2013.03.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
4 Sandroff BM, Pilutti LA, Motl RW. Does the six-minute walk test measure walking performance or physical fitness in persons with multiple sclerosis? NeuroRehabilitation 2015;37:149-55. [PMID: 26409700 DOI: 10.3233/NRE-151247] [Cited by in Crossref: 16] [Cited by in F6Publishing: 3] [Article Influence: 2.7] [Reference Citation Analysis]
5 Feys P, Bibby B, Romberg A, Santoyo C, Gebara B, de Noordhout BM, Knuts K, Bethoux F, Skjerbæk A, Jensen E, Baert I, Vaney C, de Groot V, Dalgas U. Within-day variability on short and long walking tests in persons with multiple sclerosis. Journal of the Neurological Sciences 2014;338:183-7. [DOI: 10.1016/j.jns.2014.01.001] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 3.6] [Reference Citation Analysis]
6 Cameron MH, Nilsagård YE. Measurement and Treatment of Imbalance and Fall Risk in Multiple Sclerosis Using the International Classification of Functioning, Disability and Health Model. Physical Medicine and Rehabilitation Clinics of North America 2013;24:337-54. [DOI: 10.1016/j.pmr.2012.11.009] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
7 Barin L, Vaney C, Puhan MA, von Wyl V. Recommended outcome measures for inpatient rehabilitation of multiple sclerosis are not appropriate for the patients with substantially impaired mobility. Mult Scler Relat Disord 2018;22:108-14. [PMID: 29655044 DOI: 10.1016/j.msard.2018.04.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
8 Smrtka J, Brown T, Bjorklund G. Loss of mobility and the patient burden of multiple sclerosis: expert opinion on relevance to daily clinical practice. Postgraduate Medicine 2015;128:145-51. [DOI: 10.1080/00325481.2016.1120162] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
9 Burschka JM, Keune PM, Menge U, Hofstadt-van Oy U, Oschmann P, Hoos O. An exploration of impaired walking dynamics and fatigue in multiple sclerosis. BMC Neurol 2012;12:161. [PMID: 23270547 DOI: 10.1186/1471-2377-12-161] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 4.3] [Reference Citation Analysis]
10 Paul L, Renfrew L, Freeman J, Murray H, Weller B, Mattison P, Mcconnachie A, Heggie R, Wu O, Coulter EH. Web-based physiotherapy for people affected by multiple sclerosis: a single blind, randomized controlled feasibility study. Clin Rehabil 2019;33:473-84. [DOI: 10.1177/0269215518817080] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
11 Kjølhede T, Dalgas U, Gade AB, Bjerre M, Stenager E, Petersen T, Vissing K. Acute and chronic cytokine responses to resistance exercise and training in people with multiple sclerosis: Cytokine response to resistance training. Scand J Med Sci Sports 2016;26:824-34. [DOI: 10.1111/sms.12504] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
12 Jakimovski D, Weinstock-guttman B, Hagemeier J, Vaughn CB, Kavak KS, Gandhi S, Bennett SE, Fuchs TA, Bergsland N, Dwyer MG, Benedict RH, Zivadinov R. Walking disability measures in multiple sclerosis patients: Correlations with MRI-derived global and microstructural damage. Journal of the Neurological Sciences 2018;393:128-34. [DOI: 10.1016/j.jns.2018.08.020] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
13 Skjerbæk AG, Boesen F, Petersen T, Rasmussen PV, Stenager E, Nørgaard M, Feys P, Kjeldgaard-jørgensen ML, Hvid LG, Dalgas U. Can we trust self-reported walking distance when determining EDSS scores in patients with multiple sclerosis? The Danish MS hospitals rehabilitation study. Mult Scler 2019;25:1653-60. [DOI: 10.1177/1352458518795416] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
14 Dawes H, Collett J, Meaney A, Duda J, Sackley C, Wade D, Barker K, Izadi H. Delayed Recovery of Leg Fatigue Symptoms Following a Maximal Exercise Session in People With Multiple Sclerosis. Neurorehabil Neural Repair 2014;28:139-48. [DOI: 10.1177/1545968313503218] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
15 Rosenkranz SC, Kaulen B, Zimmermann HG, Bittner AK, Dorr M, Stellmann JP. Validation of Computer-Adaptive Contrast Sensitivity as a Tool to Assess Visual Impairment in Multiple Sclerosis Patients. Front Neurosci 2021;15:591302. [PMID: 33708068 DOI: 10.3389/fnins.2021.591302] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Moumdjian L, Gervasoni E, Van Halewyck F, Eijnde BO, Wens I, Van Geel F, Van Wijmeersch B, Feys P, Van Asch P. Walking endurance and perceived symptom severity after a single maximal exercise test in persons with mild disability because of multiple sclerosis. Int J Rehabil Res 2018;41:316-22. [PMID: 30020095 DOI: 10.1097/MRR.0000000000000305] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
17 Hadouiri N, Monnet E, Gouelle A, Decavel P, Sagawa Y. Evaluation of Prolonged Walking in Persons with Multiple Sclerosis: Reliability of the Spatio-Temporal Walking Variables during the 6-Minute Walk Test. Sensors (Basel) 2021;21:3075. [PMID: 33925075 DOI: 10.3390/s21093075] [Reference Citation Analysis]
18 Beckerman H, Heine M, van den Akker LE, de Groot V. The 2-minute walk test is not a valid method to determine aerobic capacity in persons with Multiple Sclerosis. NeuroRehabilitation 2019;45:239-45. [PMID: 31498142 DOI: 10.3233/NRE-192792] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Nilsagård Y, Carling A, Davidsson O, Franzén L, Forsberg A. Comparison of trunk impairment scale versions 1.0 and 2.0 in people with multiple sclerosis: A validation study. Physiother Theory Pract 2017;33:772-9. [PMID: 28715271 DOI: 10.1080/09593985.2017.1346025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
20 Criado MB, Santos MJ, Machado J, Gonçalves AM, Greten HJ. Effects of Acupuncture on Gait of Patients with Multiple Sclerosis. The Journal of Alternative and Complementary Medicine 2017;23:852-7. [DOI: 10.1089/acm.2016.0355] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
21 Hsieh KL, Mirelman A, Shema-Shiratzky S, Galperin I, Regev K, Shen S, Schmitz-Hübsch T, Karni A, Paul F, Devos H, Sosnoff JJ, Hausdorff JM. A multi-modal virtual reality treadmill intervention for enhancing mobility and cognitive function in people with multiple sclerosis: Protocol for a randomized controlled trial. Contemp Clin Trials 2020;97:106122. [PMID: 32858229 DOI: 10.1016/j.cct.2020.106122] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
22 Arntzen EC, Straume B, Odeh F, Feys P, Normann B. Group‐based, individualized, comprehensive core stability and balance intervention provides immediate and long‐term improvements in walking in individuals with multiple sclerosis: A randomized controlled trial. Physiother Res Int 2019;25. [DOI: 10.1002/pri.1798] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
23 Hvid LG, Feys P, Baert I, Kalron A, Dalgas U. Accelerated Trajectories of Walking Capacity Across the Adult Life Span in Persons With Multiple Sclerosis: An Underrecognized Challenge. Neurorehabil Neural Repair 2020;34:360-9. [DOI: 10.1177/1545968320907074] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
24 Kjølhede T, Vissing K, Langeskov-christensen D, Stenager E, Petersen T, Dalgas U. Relationship between muscle strength parameters and functional capacity in persons with mild to moderate degree multiple sclerosis. Multiple Sclerosis and Related Disorders 2015;4:151-8. [DOI: 10.1016/j.msard.2015.01.002] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 5.1] [Reference Citation Analysis]
25 Kjølhede T, Vissing K, de Place L, Pedersen BG, Ringgaard S, Stenager E, Petersen T, Dalgas U. Neuromuscular adaptations to long-term progressive resistance training translates to improved functional capacity for people with multiple sclerosis and is maintained at follow-up. Mult Scler 2015;21:599-611. [DOI: 10.1177/1352458514549402] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 5.8] [Reference Citation Analysis]
26 Gunn H, Andrade J, Paul L, Miller L, Creanor S, Green C, Marsden J, Ewings P, Berrow M, Vickery J, Barton A, Marshall B, Zajicek J, Freeman JA. Balance Right in Multiple Sclerosis (BRiMS): a guided self-management programme to reduce falls and improve quality of life, balance and mobility in people with secondary progressive multiple sclerosis: a protocol for a feasibility randomised controlled trial. Pilot Feasibility Stud 2018;4:26. [PMID: 28770099 DOI: 10.1186/s40814-017-0168-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
27 Filli L, Werner J, Beyer G, Reuter K, Petersen JA, Weller M, Zörner B, Linnebank M. Predicting responsiveness to fampridine in gait-impaired patients with multiple sclerosis. Eur J Neurol 2019;26:281-9. [DOI: 10.1111/ene.13805] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
28 Langeskov-christensen D, Feys P, Baert I, Riemenschneider M, Stenager E, Dalgas U. Performed and perceived walking ability in relation to the Expanded Disability Status Scale in persons with multiple sclerosis. Journal of the Neurological Sciences 2017;382:131-6. [DOI: 10.1016/j.jns.2017.09.049] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 5.8] [Reference Citation Analysis]
29 Baert I, Freeman J, Smedal T, Dalgas U, Romberg A, Kalron A, Conyers H, Elorriaga I, Gebara B, Gumse J, Heric A, Jensen E, Jones K, Knuts K, Maertens de Noordhout B, Martic A, Normann B, Eijnde BO, Rasova K, Santoyo Medina C, Truyens V, Wens I, Feys P. Responsiveness and clinically meaningful improvement, according to disability level, of five walking measures after rehabilitation in multiple sclerosis: a European multicenter study. Neurorehabil Neural Repair 2014;28:621-31. [PMID: 24503204 DOI: 10.1177/1545968314521010] [Cited by in Crossref: 114] [Cited by in F6Publishing: 112] [Article Influence: 14.3] [Reference Citation Analysis]
30 Nilsagård Y, Andreasson M, Carling A, Vesterlin H. Examining the validity and sensitivity to change of the 5 and 10 sit-to-stand tests in people with multiple sclerosis: Validation study of sit-to-stand tests. Physiother Res Int 2017;22:e1681. [DOI: 10.1002/pri.1681] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
31 Leone C, Severijns D, Doležalová V, Baert I, Dalgas U, Romberg A, Bethoux F, Gebara B, Santoyo Medina C, Maamâgi H, Rasova K, Maertens de Noordhout B, Knuts K, Skjerbaek A, Jensen E, Wagner JM, Feys P. Prevalence of Walking-Related Motor Fatigue in Persons With Multiple Sclerosis: Decline in Walking Distance Induced by the 6-Minute Walk Test. Neurorehabil Neural Repair 2016;30:373-83. [PMID: 26216790 DOI: 10.1177/1545968315597070] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 6.7] [Reference Citation Analysis]
32 Gunn H, Andrade J, Paul L, Miller L, Creanor S, Stevens K, Green C, Ewings P, Barton A, Berrow M, Vickery J, Marshall B, Zajicek J, Freeman J. A self-management programme to reduce falls and improve safe mobility in people with secondary progressive MS: the BRiMS feasibility RCT. Health Technol Assess 2019;23:1-166. [PMID: 31217069 DOI: 10.3310/hta23270] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
33 Wens I, Hansen D. Muscle Strength, But Not Muscle Oxidative Capacity, Varies Between the Morning and the Afternoon in Patients with Multiple Sclerosis: A Pilot Study. Am J Phys Med Rehabil 2017;96:828-30. [PMID: 28134660 DOI: 10.1097/PHM.0000000000000703] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
34 Drużbicki M, Guzik A, Przysada G, Phd LP, Brzozowska-Magoń A, Cygoń K, Boczula G, Bartosik-Psujek H. Effects of Robotic Exoskeleton-Aided Gait Training in the Strength, Body Balance, and Walking Speed in Individuals With Multiple Sclerosis: A Single-Group Preliminary Study. Arch Phys Med Rehabil 2021;102:175-84. [PMID: 33181115 DOI: 10.1016/j.apmr.2020.10.122] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
35 Hoang PD, Gandevia SC, Herbert RD. Prevalence of joint contractures and muscle weakness in people with multiple sclerosis. Disability and Rehabilitation 2013;36:1588-93. [DOI: 10.3109/09638288.2013.854841] [Cited by in Crossref: 49] [Cited by in F6Publishing: 42] [Article Influence: 5.4] [Reference Citation Analysis]
36 Flachenecker P, Bures AK, Gawlik A, Weiland AC, Kuld S, Gusowski K, Streber R, Pfeifer K, Tallner A. Efficacy of an Internet-Based Program to Promote Physical Activity and Exercise after Inpatient Rehabilitation in Persons with Multiple Sclerosis: A Randomized, Single-Blind, Controlled Study. Int J Environ Res Public Health 2020;17:E4544. [PMID: 32599767 DOI: 10.3390/ijerph17124544] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
37 Spina E, Carotenuto A, Aceto MG, Cerillo I, Silvestre F, Arace F, Paone P, Orefice G, Iodice R. The effects of mechanical focal vibration on walking impairment in multiple sclerosis patients: A randomized, double-blinded vs placebo study. RNN 2016;34:869-76. [DOI: 10.3233/rnn-160665] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
38 Taul-Madsen L, Connolly L, Dennett R, Freeman J, Dalgas U, Hvid LG. Is Aerobic or Resistance Training the Most Effective Exercise Modality for Improving Lower Extremity Physical Function and Perceived Fatigue in People With Multiple Sclerosis? A Systematic Review and Meta-analysis. Arch Phys Med Rehabil 2021:S0003-9993(21)00307-5. [PMID: 33901439 DOI: 10.1016/j.apmr.2021.03.026] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
39 Rosenblum U, Melzer I. Reliability and Concurrent Validity of the Narrow Path Walking Test in Persons With Multiple Sclerosis. J Neurol Phys Ther 2017;41:43-51. [PMID: 27977520 DOI: 10.1097/NPT.0000000000000161] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
40 Straudi S, Manfredini F, Lamberti N, Martinuzzi C, Maietti E, Basaglia N. Robot-assisted gait training is not superior to intensive overground walking in multiple sclerosis with severe disability (the RAGTIME study): A randomized controlled trial. Mult Scler 2020;26:716-24. [DOI: 10.1177/1352458519833901] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 7.7] [Reference Citation Analysis]
41 Kieseier BC, Pozzilli C. Assessing walking disability in multiple sclerosis. Mult Scler 2012;18:914-24. [DOI: 10.1177/1352458512444498] [Cited by in Crossref: 156] [Cited by in F6Publishing: 148] [Article Influence: 15.6] [Reference Citation Analysis]
42 Cederberg KLJ, Sikes EM, Bartolucci AA, Motl RW. Walking endurance in multiple sclerosis: Meta-analysis of six-minute walk test performance. Gait Posture 2019;73:147-53. [PMID: 31326830 DOI: 10.1016/j.gaitpost.2019.07.125] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
43 Feys P, Severijns D, Vantenderloo S, Knuts K, Hannes D, Gijbels D, Wens I. Spatio-temporal gait parameters change differently according to speed instructions and walking history in MS patients with different ambulatory dysfunction. Mult Scler Relat Disord 2013;2:238-46. [PMID: 25877730 DOI: 10.1016/j.msard.2013.01.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
44 Straudi S, De Marco G, Martinuzzi C, Baroni A, Lamberti N, Brondi L, Da Roit M, Pizzongolo LDM, Basaglia N, Manfredini F. Combining a supervised and home-based task-oriented circuit training improves walking endurance in patients with multiple sclerosis. The MS_TOCT randomized-controlled trial. Multiple Sclerosis and Related Disorders 2022. [DOI: 10.1016/j.msard.2022.103721] [Reference Citation Analysis]
45 Cohen JA, Cameron MH, Goldman MD, Goodman AD, Miller AE, Rollins A, Llorens L, Patni R, Elfont R, Johnson R. A Phase 3, double-blind, placebo-controlled efficacy and safety study of ADS-5102 (Amantadine) extended-release capsules in people with multiple sclerosis and walking impairment. Mult Scler 2021;:13524585211035333. [PMID: 34449295 DOI: 10.1177/13524585211035333] [Reference Citation Analysis]
46 Goda A, Morishima Y, Yokohara N, Suzuki T, Ohgi S, Mizushima T. Validity and Reliability of a 2-Min Walk Test to Assess the Exercise Capacity in Vertebral Compression Fracture Patients: A Pilot Study. Phys Ther Res 2019;22:26-30. [PMID: 31289709 DOI: 10.1298/ptr.E9958] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
47 Tramontano M, Martino Cinnera A, Manzari L, Tozzi FF, Caltagirone C, Morone G, Pompa A, Grasso MG. Vestibular rehabilitation has positive effects on balance, fatigue and activities of daily living in highly disabled multiple sclerosis people: A preliminary randomized controlled trial. Restor Neurol Neurosci 2018;36:709-18. [PMID: 30412513 DOI: 10.3233/RNN-180850] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
48 Phan-Ba R, Calay P, Grodent P, Delrue G, Lommers E, Delvaux V, Moonen G, Belachew S. Motor fatigue measurement by distance-induced slow down of walking speed in multiple sclerosis. PLoS One 2012;7:e34744. [PMID: 22514661 DOI: 10.1371/journal.pone.0034744] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
49 Kristensen SB, Bibby BM. A bivariate logistic regression model based on latent variables. Stat Med 2020;39:2962-79. [PMID: 32678481 DOI: 10.1002/sim.8587] [Reference Citation Analysis]
50 Mackney J, Harrold M, Jenkins S, Fehlberg R, Thomas L, Havill K, Jacques A, Hill K. Survivors of Acute Lung Injury Have Greater Impairments in Strength and Exercise Capacity Than Survivors of Other Critical Illnesses as Measured Shortly After ICU Discharge. J Intensive Care Med 2020;:885066620981899. [PMID: 33334223 DOI: 10.1177/0885066620981899] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
51 van der Maas NA. Patient-reported questionnaires in MS rehabilitation: responsiveness and minimal important difference of the multiple sclerosis questionnaire for physiotherapists (MSQPT). BMC Neurol 2017;17:50. [PMID: 28302081 DOI: 10.1186/s12883-017-0834-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
52 Goodman AD, Brown TR, Schapiro RT, Klingler M, Cohen R, Blight AR. A pooled analysis of two phase 3 clinical trials of dalfampridine in patients with multiple sclerosis. Int J MS Care 2014;16:153-60. [PMID: 25337058 DOI: 10.7224/1537-2073.2013-023] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
53 Stellmann JP, Vettorazzi E, Poettgen J, Heesen C. A 3meter Timed Tandem Walk is an early marker of motor and cerebellar impairment in fully ambulatory MS patients. J Neurol Sci 2014;346:99-106. [PMID: 25156343 DOI: 10.1016/j.jns.2014.08.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
54 Straudi S, Fanciullacci C, Martinuzzi C, Pavarelli C, Rossi B, Chisari C, Basaglia N. The effects of robot-assisted gait training in progressive multiple sclerosis: A randomized controlled trial. Mult Scler 2016;22:373-84. [PMID: 26658817 DOI: 10.1177/1352458515620933] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 6.1] [Reference Citation Analysis]
55 Larson RD, Larson DJ, Baumgartner TB, White LJ. Repeatability of the timed 25-foot walk test for individuals with multiple sclerosis. Clin Rehabil 2013;27:719-23. [PMID: 23426567 DOI: 10.1177/0269215512470269] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
56 Carling A, Forsberg A, Gunnarsson M, Nilsagård Y. CoDuSe group exercise programme improves balance and reduces falls in people with multiple sclerosis: A multi-centre, randomized, controlled pilot study. Mult Scler 2017;23:1394-404. [PMID: 27834736 DOI: 10.1177/1352458516677591] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
57 Xie X, Sun H, Zeng Q, Lu P, Zhao Y, Fan T, Huang G. Do Patients with Multiple Sclerosis Derive More Benefit from Robot-Assisted Gait Training Compared with Conventional Walking Therapy on Motor Function? A Meta-analysis. Front Neurol 2017;8:260. [PMID: 28659856 DOI: 10.3389/fneur.2017.00260] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
58 Scalzitti DA, Harwood KJ, Maring JR, Leach SJ, Ruckert EA, Costello E. Validation of the 2-Minute Walk Test with the 6-Minute Walk Test and Other Functional Measures in Persons with Multiple Sclerosis. Int J MS Care 2018;20:158-63. [PMID: 30150899 DOI: 10.7224/1537-2073.2017-046] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 5.5] [Reference Citation Analysis]
59 Miller L, McFadyen A, Lord AC, Hunter R, Paul L, Rafferty D, Bowers R, Mattison P. Functional Electrical Stimulation for Foot Drop in Multiple Sclerosis: A Systematic Review and Meta-Analysis of the Effect on Gait Speed. Arch Phys Med Rehabil 2017;98:1435-52. [PMID: 28088382 DOI: 10.1016/j.apmr.2016.12.007] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
60 Vienne-Jumeau A, Quijoux F, Vidal PP, Ricard D. Value of gait analysis for measuring disease severity using inertial sensors in patients with multiple sclerosis: protocol for a systematic review and meta-analysis. Syst Rev 2019;8:15. [PMID: 30621765 DOI: 10.1186/s13643-018-0918-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
61 Sikes EM, Cederberg KL, Sandroff BM, Bartolucci A, Motl RW. Quantitative Synthesis of Timed 25-Foot Walk Performance in Multiple Sclerosis. Arch Phys Med Rehabil 2020;101:524-34. [PMID: 31669296 DOI: 10.1016/j.apmr.2019.08.488] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
62 Soler B, Ramari C, Valet M, Dalgas U, Feys P. Clinical assessment, management, and rehabilitation of walking impairment in MS: an expert review. Expert Rev Neurother 2020;20:875-86. [PMID: 32729742 DOI: 10.1080/14737175.2020.1801425] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
63 Tajali S, Shaterzadeh-Yazdi MJ, Negahban H, van Dieën JH, Mehravar M, Majdinasab N, Saki-Malehi A, Mofateh R. Predicting falls among patients with multiple sclerosis: Comparison of patient-reported outcomes and performance-based measures of lower extremity functions. Mult Scler Relat Disord 2017;17:69-74. [PMID: 29055478 DOI: 10.1016/j.msard.2017.06.014] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 5.8] [Reference Citation Analysis]
64 Stellmann JP, Young KL, Vettorazzi E, Pöttgen J, Heesen C. No relevant impact of ambient temperature on disability measurements in a large cohort of patients with multiple sclerosis. Eur J Neurol 2017;24:851-7. [PMID: 28544407 DOI: 10.1111/ene.13301] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
65 Giordano A, Clarelli F, Cannizzaro M, Mascia E, Santoro S, Sorosina M, Ferrè L, Leocani L, Esposito F. BDNF Val66Met Polymorphism Is Associated With Motor Recovery After Rehabilitation in Progressive Multiple Sclerosis Patients. Front Neurol 2022;13:790360. [PMID: 35265024 DOI: 10.3389/fneur.2022.790360] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 Kaufmann M, Vaney C, Barin L, Liu X, von Wyl V. Long-term worsening of different body functions in persons with progressive multiple sclerosis. Mult Scler J Exp Transl Clin 2020;6:2055217320964514. [PMID: 33110620 DOI: 10.1177/2055217320964514] [Reference Citation Analysis]
67 Frechette ML, Meyer BM, Tulipani LJ, Gurchiek RD, Mcginnis RS, Sosnoff JJ. Next Steps in Wearable Technology and Community Ambulation in Multiple Sclerosis. Curr Neurol Neurosci Rep 2019;19. [DOI: 10.1007/s11910-019-0997-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
68 Freeman J, Walters R, Ingram W, Slade A, Hobart J, Zajicek J. Evaluating change in mobility in people with multiple sclerosis: relative responsiveness of four clinical measures. Mult Scler 2013;19:1632-9. [PMID: 23530002 DOI: 10.1177/1352458513482373] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
69 Socie MJ, Sosnoff JJ. Gait variability and multiple sclerosis. Mult Scler Int 2013;2013:645197. [PMID: 23533759 DOI: 10.1155/2013/645197] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 3.1] [Reference Citation Analysis]
70 Matza LS, Stewart KD, Phillips G, Delio P, Naismith RT. Development of a brief clinician-reported outcome measure of multiple sclerosis signs and symptoms: The Clinician Rating of Multiple Sclerosis (CRoMS). Mult Scler Relat Disord 2019;35:253-61. [PMID: 31437740 DOI: 10.1016/j.msard.2019.06.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
71 Gunn H, Stevens KN, Creanor S, Andrade J, Paul L, Miller L, Green C, Ewings P, Barton A, Berrow M, Vickery J, Marshall B, Zajicek J, Freeman JA. Balance Right in Multiple Sclerosis (BRiMS): a feasibility randomised controlled trial of a falls prevention programme. Pilot Feasibility Stud 2021;7:2. [PMID: 33390184 DOI: 10.1186/s40814-020-00732-9] [Reference Citation Analysis]
72 Nguemeni C, Hiew S, Kögler S, Homola GA, Volkmann J, Zeller D. Split-Belt Training but Not Cerebellar Anodal tDCS Improves Stability Control and Reduces Risk of Fall in Patients with Multiple Sclerosis. Brain Sciences 2022;12:63. [DOI: 10.3390/brainsci12010063] [Reference Citation Analysis]
73 Hibner BA, Hilgenkamp TIM, Schroeder EC, Motl RW, Bollaert RE, Griffith G, Grigoriadis G, Baynard T, Fernhall B. Physical activity and peak oxygen consumption are associated with walking in multiple sclerosis. Mult Scler Relat Disord 2020;40:101941. [PMID: 31954226 DOI: 10.1016/j.msard.2020.101941] [Reference Citation Analysis]
74 Slavkovic S, Golubovic S, Vojnovic M, Nadj C. Influence of Cognitive and Motor Abilities on the Level of Current Functioning in People with Multiple Sclerosis. Zdr Varst 2019;58:54-61. [PMID: 30984295 DOI: 10.2478/sjph-2019-0007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
75 Hvid LG, Stenager E, Dalgas U. Objectively assessed physiological, physical, and cognitive function along with patient-reported outcomes during the first 2 years of Alemtuzumab treatment in multiple sclerosis: a prospective observational study. J Neurol 2022. [PMID: 35482080 DOI: 10.1007/s00415-022-11134-7] [Reference Citation Analysis]
76 Meyer C, Killeen T, Easthope CS, Curt A, Bolliger M, Linnebank M, Zörner B, Filli L. Familiarization with treadmill walking: How much is enough? Sci Rep 2019;9:5232. [PMID: 30914746 DOI: 10.1038/s41598-019-41721-0] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 10.3] [Reference Citation Analysis]
77 Bethoux F. Gait disorders in multiple sclerosis. Continuum (Minneap Minn) 2013;19:1007-22. [PMID: 23917098 DOI: 10.1212/01.CON.0000433286.92596.d5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
78 Chen S, Sierra S, Shin Y, Goldman MD. Gait Speed Trajectory During the Six-Minute Walk Test in Multiple Sclerosis: A Measure of Walking Endurance. Front Neurol 2021;12:698599. [PMID: 34381416 DOI: 10.3389/fneur.2021.698599] [Reference Citation Analysis]
79 Rabadi MH, Kreymborg K, Vincent AS. Sustained-release fampridine (4-aminopyridine) in multiple sclerosis: efficacy and impact on motor function. Drugs R D 2013;13:175-81. [PMID: 23873597 DOI: 10.1007/s40268-013-0020-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
80 Behrens J, Pfüller C, Mansow-Model S, Otte K, Paul F, Brandt AU. Using perceptive computing in multiple sclerosis - the Short Maximum Speed Walk test. J Neuroeng Rehabil 2014;11:89. [PMID: 24886525 DOI: 10.1186/1743-0003-11-89] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 4.1] [Reference Citation Analysis]
81 Seebacher B, Kuisma R, Glynn A, Berger T. Rhythmic cued motor imagery and walking in people with multiple sclerosis: a randomised controlled feasibility study. Pilot Feasibility Stud 2015;1:25. [PMID: 27965804 DOI: 10.1186/s40814-015-0021-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
82 Lamers I, Cattaneo D, Chen CC, Bertoni R, Van Wijmeersch B, Feys P. Associations of upper limb disability measures on different levels of the International Classification of Functioning, Disability and Health in people with multiple sclerosis. Phys Ther 2015;95:65-75. [PMID: 25190063 DOI: 10.2522/ptj.20130588] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
83 Gor-García-Fogeda MD, Cano-de-la-Cuerda R, Daly JJ, Molina-Rueda F. Construct Validity of the Gait Assessment and Intervention Tool (GAIT) in People With Multiple Sclerosis. PM R 2021;13:307-13. [PMID: 32449255 DOI: 10.1002/pmrj.12423] [Reference Citation Analysis]
84 Sola-Valls N, Blanco Y, Sepúlveda M, Martinez-Hernandez E, Saiz A. Telemedicine for Monitoring MS Activity and Progression. Curr Treat Options Neurol 2015;17:47. [PMID: 26423914 DOI: 10.1007/s11940-015-0377-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
85 Henney HR 3rd, Blight AR. Walking impairment in patients with multiple sclerosis - a new therapeutic approach and clinical potential of dalfampridine extended release tablets. Degener Neurol Neuromuscul Dis 2012;2:53-64. [PMID: 30890878 DOI: 10.2147/DNND.S19839] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
86 Stellmann JP, Neuhaus A, Götze N, Briken S, Lederer C, Schimpl M, Heesen C, Daumer M. Ecological validity of walking capacity tests in multiple sclerosis. PLoS One 2015;10:e0123822. [PMID: 25879750 DOI: 10.1371/journal.pone.0123822] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 4.7] [Reference Citation Analysis]
87 Kremer TR, Van Dillen LR, Wagner JM. Dynamometer-based measure of spasticity confirms limited association between plantarflexor spasticity and walking function in persons with multiple sclerosis. J Rehabil Res Dev 2014;51:975-84. [PMID: 25356797 DOI: 10.1682/JRRD.2013.08.0186] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
88 Seebacher B, Helmlinger B, Pinter D, Ehling R, Hegen H, Ropele S, Reishofer G, Enzinger C, Brenneis C, Deisenhammer F. Effects of actual and imagined music-cued gait training on motor functioning and brain activity in people with multiple sclerosis: protocol of a randomised parallel multicentre trial. BMJ Open 2022;12:e056666. [PMID: 35131834 DOI: 10.1136/bmjopen-2021-056666] [Reference Citation Analysis]
89 Sieljacks PS, Søberg CA, Michelsen A, Dalgas U, Hvid LG. Lower extremity muscle strength across the adult lifespan in multiple sclerosis: Implications for walking and stair climbing capacity. Experimental Gerontology 2020;139:111025. [DOI: 10.1016/j.exger.2020.111025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
90 Zörner B, Hostettler P, Meyer C, Killeen T, Gut P, Linnebank M, Weller M, Straumann D, Filli L. Prognosis of walking function in multiple sclerosis supported by gait pattern analysis. Multiple Sclerosis and Related Disorders 2022. [DOI: 10.1016/j.msard.2022.103802] [Reference Citation Analysis]
91 Pin TW. Psychometric properties of 2-minute walk test: a systematic review. Arch Phys Med Rehabil 2014;95:1759-75. [PMID: 24814460 DOI: 10.1016/j.apmr.2014.03.034] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]
92 Li Y, Guo Y. Wiki-Health: From Quantified Self to Self-Understanding. Future Generation Computer Systems 2016;56:333-59. [DOI: 10.1016/j.future.2015.08.008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
93 Dalgas U, Langeskov-christensen M, Skjerbæk A, Jensen E, Baert I, Romberg A, Santoyo Medina C, Gebara B, Maertens de Noordhout B, Knuts K, Béthoux F, Rasova K, Severijns D, Bibby B, Kalron A, Norman B, Van Geel F, Wens I, Feys P. Is the impact of fatigue related to walking capacity and perceived ability in persons with multiple sclerosis? A multicenter study. Journal of the Neurological Sciences 2018;387:179-86. [DOI: 10.1016/j.jns.2018.02.026] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
94 Jones CD, Cederberg KL, Sikes EM, Wylie GR, Motl RW, Sandroff BM. Walking and cognitive performance in adults with multiple sclerosis: Do age and fatigability matter? Mult Scler Relat Disord 2020;42:102136. [PMID: 32387975 DOI: 10.1016/j.msard.2020.102136] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
95 Ramari C, Feys P, Gaemelke T, Hvid LG, Baert I, Kalron A, Dalgas U; RIMS multicenter study group. Predicting long walking capacity from the timed 25-foot walk test in persons with multiple sclerosis - a potential simple aid to assist ambulation scoring? Mult Scler Relat Disord 2021;48:102706. [PMID: 33461129 DOI: 10.1016/j.msard.2020.102706] [Reference Citation Analysis]